Active Development

Reset

Delivery Type

Reset

Duration Type

Reset

Developer

Reset

User

Reset

Hormonal

Reset

Development Stage

Reset

Potential MPT

Reset

API

Reset
Displaying 161 - 170 of 243
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Intrauterine
Developer: Contrel Research, Belgium
Active Status: Yes
User: Female
Mode: Yes
Delivery Type: Intrauterine
Developer: Contrel Research, Belgium
Project Stage: Regulatory
Alternative Name: ZK 98.299; ZK 98 299
Active Status: No
User: Female
Mode: Yes
Developer: Schering AG
Project Stage: Pre-clinical
Active Status: Unknown
User: Male
Mode: Yes
Delivery Type: Oral
Developer: University of Washington, GlaxoSmithKline, NICHD
Project Stage: Phase I
Active Status: No
User: Female
Mode: No
Delivery Type: Barrier
Developer: NIAID, NICHD, Origami Healthcare Products, Inc., Strata Various Product Design
Project Stage: Phase II
Active Status: Yes
User: Male
Mode: Yes
Developer: University of Kansas Medical Center, University of Minnesota
Role in reproduction: Sperm Function
Project Stage: Lead Optimization
Active Status: Yes
User: Female
Mode: No
Delivery Type: Barrier, Vaginal Ring
Developer: Dare BioScience Inc.
Project Stage: Phase II
Active Status: Unknown
User: Female
Mode: No
Delivery Type: Barrier
Active Status: No
User: Female
Mode: No
Delivery Type: Oral
Developer: Innolytics LLC
Project Stage: Lead Optimization
PC6
Alternative Name: Proprotein convertase 6
Target
Active Status: Unknown
Mode: No
Developer: CONRAD, Prince Henry's Institute of Medical Research, Australia
Role in reproduction: Implantation
Project Stage: Target Validation

Pages

CSV